GlycoMimetics, Inc.
(NASDAQ GM: GLYC)
Rigrodsky Law, P.A. is investigating GlycoMimetics, Inc. (“GlycoMimetics”) regarding possible breaches of fiduciary duties and other violations of law related to GlycoMimetics’s agreement to merge with Crescent Biopharma, Inc.